跳至主要内容
临床试验/NCT06870799
NCT06870799招募中不适用

Randomized Controlled Trial Comparing Closed Face Masks vs Surface Guided Radiation Therapy for Head and Neck Radiotherapy

University of Zurich1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2025年5月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
25
试验地点
1
主要终点
Patient discomfort, anxiety and pain

研究概览

简要总结

At present, open-face masks are used only in patients with claustrophobic anxiety, while all other patients are still immobilized with closed masks, thereby overlooking the need for improvement in patient comfort. Closed face masks in patients undergoing head and neck irradiation have never been compared to no masks in the setting of a randomized clinical trial, but only in feasibility trials. A randomized clinical trial may establish the role of no masks in terms of patient comfort, preference and setup accuracy in all patients.

详细描述

Once eligibility has been confirmed and upon randomization, patients will begin treatment either with an immobilization mask (A) or no mask (B). One individual immobilization mask and AccuForm cushion will be fabricated for every single patient. All positioning setup information used for subsequent treatment sessions will be documented. One simulation CT/MRI will be acquired and one treatment plan for each setup. After image acquisition, the mask will be removed and stored for treatment. After the simulation, the patients will be asked to fill out a questionnaire evaluating their comfort/anxiety/pain in regards to the setup as a baseline assessment. The patients will be treated with 6 MV from a linear accelerator (Truebeam, Varian Medical Systems, Palo Alto, CA). Dose prescription and treatment planning objectives of the individual patient will be defined by the standard treatment protocol depending on the patient's disease and treatment intention. Before each treatment session, the patient will be positioned on the treatment couch with the designated immobilization material. Conebeam-CT (CBCT) images will be acquired followed by automatic/manual setup correction compared to simulation CT/MRI; a CBCT image will be acquired after the treatment session once a week and at the first three fractions with mask and no mask. The CBCT procedure is a part of the standard treatment protocol for head-and-neck irradiation. Data on CBCT imaging in the form of translational and rotational shifts will be used to measure and compare setup uncertainties (inter-fraction and intra-fraction accuracy) between the two arms. In the no mask arm, Align RT® (Vision RT Ltd., UK) an SGRT system will be used in addition to CBCT imaging, to evaluate translational and rotational motions during treatment and for initial set up and also Gate during treatment. The SGRT system will not be used in patients with immobilization masks on. On the first day of treatment and weekly thereafter (immediately after treatment), the patients will be asked to fill out the same questionnaire as in Simulation for a comfort/anxiety/pain evaluation. As standard practice, patients typically receive another CT simulation during the second half of their treatment, to allow for adjustments to their radiation plan. This is typically due to factors such as weight loss, swelling, tumour or anatomical changes. If necessary, a new mask is also created to account for such changes. This workflow will apply to this study and participants. At the very last treatment session, they will answer the question on their mask or no mask preference.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Written informed consent according to Swiss law and ICH/GCP regulations before any trial specific procedures;
  • •Indication for head and neck radiotherapy irrespective of tumor type;
  • •Age: ≥ 18 years old;
  • •Karnofsky performance status ≥70;
  • •Patients who are willing and able to comply with scheduled visits, treatment, and other trial procedures.

排除标准

  • •Prior head and neck irradiation;
  • •Women who are pregnant or breast feeding;
  • •Intention to become pregnant during the course of the trial;
  • •Lack of safe contraception, defined as: Female participants of childbearing potential, not using and not willing to continue using a medically reliable method of contraception for the entire study duration, such as oral, injectable, or implantable contraceptives, or intrauterine contraceptive devices, or who are not using any other method considered sufficiently reliable by the investigator in individual cases;
  • •Known or suspected non-compliance, drug or alcohol abuse;
  • •Inability to follow the procedures of the trial, e.g. due to language problems of the participant;
  • •Enrolment of the investigator, his/her family members, employees and other dependent persons.
  • •One of the following Tumor Types: Nasopharynx, Sinunasal, patients with CTV within 5 mm of eyes or spinal cord.

研究组 & 干预措施

Closed Mask followed by No Mask

Other

The first half of the treatment is delivered with a face mask, the second half is delivered without mask using surface guidance only

干预措施: Surface guided radiation therapy (Device)

Closed Mask followed by No Mask

Other

The first half of the treatment is delivered with a face mask, the second half is delivered without mask using surface guidance only

干预措施: Closed face mask (Device)

No Mask followed by Closed Mask

Other

The first half of the treatment is delivered without mask using surface guidance only, the second half is delivered with a face mask

干预措施: Surface guided radiation therapy (Device)

No Mask followed by Closed Mask

Other

The first half of the treatment is delivered without mask using surface guidance only, the second half is delivered with a face mask

干预措施: Closed face mask (Device)

结局指标

主要结局

Patient discomfort, anxiety and pain

时间窗: weekly from enrollment to end of treatment up to 7 weeks

Patients are asked to fill in a short questionnaire to rate their discomfort, anxiety and pain on a visual analogue scale ranging from 0 (=none) to 10 (=extreme)

overall preference

时间窗: once at end of treatment (max. 7 weeks)

patients are asked to answer the question which treatment modality they preferred (with mask or without mask)

次要结局

  • Serious adverse events(continuously during treatment up to 7 weeks)
  • Setup uncertainties(during treatment before every treatment fraction, 5-6 times per week up to 7 weeks)
  • intra-fraction accuracy(during treatment before every treatment fraction, 5-6 times per week up to 7 weeks)
  • Device Deficiencies of the surface guidance system(continuously during treatment up to 7 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验